Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrident Royalties Regulatory News (TRR)

Share Price Information for Trident Royalties (TRR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.70
Bid: 47.60
Ask: 47.80
Change: 0.10 (0.21%)
Spread: 0.20 (0.42%)
Open: 47.70
High: 47.70
Low: 47.00
Prev. Close: 47.60
TRR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Trident Royalties plc

21 Jun 2024 15:29

RNS Number : 3974T
Caisse Federale De Credit Mutuel
21 June 2024
 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/ DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Caisse Fédérale de Crédit Mutuel

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Trident Royalties plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

June 20th, 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

No

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 4 389 528

 

1.49%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

4 389 528

 

1.49%

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1©, copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

a) Purchases and sales

 

Class of relevant security

Purchase /sale

 

Number of securities

Price per unit

 

1p ordinary

 

1p ordinary

 

Purchase

 

Purchase

 

 

 

 

382 476

 

382 476

 

47.833460 Gbp

 

47.833460 Gbp

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

June 21th , 2024

Contact name:

Marie Metauer

Telephone number:

+33 3 53 48 75 77

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETQKDBPFBKKAAB
Date   Source Headline
29th Nov 20237:00 amRNSNew Low-Cost Revolving Credit Facility
21st Nov 20237:00 amRNSCompletion of Copper Royalty Acquisition
8th Nov 20237:00 amRNSAcquisition of US Copper Rich Polymetallic Royalty
7th Nov 20234:39 pmRNSHolding(s) in Company
6th Nov 20239:00 amRNSNotice of Investor Presentation
6th Nov 20237:00 amRNSQ3 2023 Activities Update
1st Nov 20237:00 amRNSNotice of Q3 2023 Activities Update
18th Oct 20237:00 amRNSMajor Resource Upgrade: Paradox Basin Royalty
21st Sep 20237:00 amRNSUpdate on Paradox Basin Royalty
18th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSHolding(s) in Company
8th Sep 20232:19 pmRNSHolding(s) in Company
4th Sep 20237:01 amRNSAcquisition of Advanced Stage Lithium Royalty
4th Sep 20237:00 amRNSCompletion of Dandoko Royalty Acquisition
1st Sep 20237:00 amRNSPortfolio Update: Sonora Lithium Royalty
21st Aug 20237:00 amRNSAcquisition of Major Gold Exploration Royalty
14th Aug 20237:00 amRNSAppointment of Non-Executive Director
7th Aug 20237:00 amRNSPortfolio Update: Positive Asset-Level Progress
31st Jul 202310:00 amRNSCorporate Presentation
31st Jul 20237:00 amRNSQ2 2023 Activities Update
19th Jul 20237:00 amRNSPortfolio Update: Thacker Pass Lithium Royalty
11th Jul 20237:00 amRNSDirector Share Purchase
10th Jul 20237:00 amRNSDirector Share Purchase
29th Jun 202311:52 amRNSResult of AGM
6th Jun 20234:50 pmRNSPosting of Annual Report and Notice of AGM
5th Jun 20237:00 amRNS2022 Full Year Results and Notice of AGM
18th May 20237:00 amRNSPortfolio Update: Thacker Pass Lithium Royalty
15th May 20237:00 amRNSAcquisition of Near-Production Silver Royalty
12th May 20237:00 amRNSNotice of Investor Presentation
3rd May 20235:45 pmRNSDirector Share Purchase
3rd May 20237:00 amRNSQ1 2023 Activities Update
28th Apr 20237:00 amRNSPortfolio Update: Sonora Lithium Royalty
5th Apr 20237:00 amRNSAdmission to Trading on OTCQX in the US
10th Mar 202310:08 amRNSHolding(s) in Company
3rd Mar 20237:00 amRNSPortfolio Update: Thacker Pass Lithium Royalty
23rd Feb 20233:14 pmRNSPortfolio Update: Thacker Pass Lithium Royalty
23rd Feb 20237:00 amRNSCompletion of Gold Royalties Sale
17th Feb 20237:00 amRNSPortfolio Update: Thacker Pass Lithium Royalty
13th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSNotice of Investor Presentation
8th Feb 20237:00 amRNSPortfolio Update: Thacker Pass - Favourable Ruling
3rd Feb 20235:16 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSPortfolio Update: Thacker Pass Lithium Royalty
31st Jan 20235:30 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSQ4 2022 Activities Update
17th Jan 20237:00 amRNSShare Awards and Non-executive Director Fees
9th Jan 20237:00 amRNSThacker Pass Litigation Update
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSSale of Gold Royalties and Debt Restructure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.